… safety considerations is lacking. The objective of this study was to perform a meta-analysis
of head-to-head randomized controlled trials evaluating the immunogenicity and safety of a …

… referred as PCV-10, 11-valent conjugate pneumococcal vaccine (PCV-11) and 13-valent …
safety profiles of PCVs following first dose were evaluated among infants in this meta-analysis […

… Evidence from this network meta-analysis could help to guide vaccination strategies, and
we recommend considering these serotype-specific differences in efficacy in future PCV health-…

… safety and immunogenicity data compared with the previously recommended … 13-valent
pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine …

… Pooled data from one large meta-analysis has shown purified capsular polysaccharide
vaccines in … A second meta-analysis showed that PPV23 was not effective against non-invasive …

… serotypes contained in the 13-valent PCV (PCV13) but not in PCV7. Disease due to
grouped serotypes contained in the 23-valent pneumococcal polysaccharide vaccine (PPV23) …

… failures or breakthrough cases after the indicated number of doses, including only cases with
serotype information available; PCV13, 13-valent pneumococcal conjugate vaccine; PCV10…

… The data obtained were only sufficient to perform a meta-analysis for safety. … and cost-effectiveness
of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children …

… in young children globally. The introduction of 7-valent pneumococcal conjugate vaccine
(… impact in preventing pneumococcal disease in both vaccinated children and unvaccinated …

… The outcomes of our meta-analysis were pooled using relative risks (RRs) with a random …
were declared safe by the WHO (18). However, an up-to-date summary and meta-analysis of …